Quantcast

Latest Vermillion Inc. Stories

2014-08-21 16:24:52

AUSTIN, Texas, Aug. 21, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed Holly B. Bauzon as Vice President of Sales and Managed Markets. Ms. Bauzon has a proven track record in both increasing sales traction and expanding payer coverage for laboratory services companies. She has more than 20 years of healthcare experience, most recently with PerkinElmer, Inc., where she held the...

2014-08-14 16:26:51

AUSTIN, Texas, Aug. 14, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for the quarter ended June 30, 2014. Q2 2014 Key Developments -- Opened ASPiRA LABS, Inc., a CLIA certified clinical laboratory which specializes in applying biomarker-based technologies that address critical needs in the management of gynecologic cancers, on June 23, 2014....

2014-08-14 08:30:17

AUSTIN, Texas, Aug. 14, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed David Jansen as Vice President of Marketing. In addition, the company has created the new position of Vice President of Sales and Managed Markets, which will be filled and announced shortly. David Jansen has been hired to the new position of Vice President of Marketing. David joins us from Myriad Genetics,...

2014-07-31 08:37:22

AUSTIN, Texas, July 31, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, August 14, 2014, at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2014. Financial results will be issued in a press release prior to the call. Vermillion's Chairman, President and CEO James LaFrance will host the call, followed by a question and...

2014-07-28 12:28:11

AUSTIN, Texas, July 28, 2014 /PRNewswire/ -- Medical experts representing Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will present on ASPiRA LABS, its new CLIA-certified reference laboratory, at the American Association for Clinical Chemistry's annual (AACC) meeting on July 31 at 10 a.m. CST. ASPiRA LABS provides expert diagnostic services, including OVA1® and Longitudinal CA 125 testing, which support...

2014-06-17 16:26:07

AUSTIN, Texas, June 17, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed Dr. Judith K. Wolf to the new position of chief medical officer, effective September 15, 2014. Dr. Wolf is a highly accomplished, widely published and active professional in the field of gynecologic cancer. Over the last eight years, she has held numerous academic and administrative positions at the...

2014-05-15 16:28:30

AUSTIN, Texas, May 15, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for the quarter ended March 31, 2014. Q1 2014 Key Developments -- Formed ASPiRA LABS, Inc., a clinical laboratory which will specialize in applying biomarker-based technologies that address critical needs in the management of gynecologic cancers. ASPiRA LABS will provide diagnostic...

2014-05-08 16:28:16

AUSTIN, Texas, May 8, 2014 /PRNewswire/ -- A new research collaboration anchored by Moffitt Cancer Center in Tampa, Fla., was announced today in conjunction with World Ovarian Cancer Day. The purpose of the study is to produce clinical and economic data to support a new value-based practice model that may improve survival, quality of life and cost-effectiveness of care for patients with ovarian cancer. The study will be led by Johnathan M. Lancaster, M.D., Ph.D., a gynecologic...

2014-05-01 08:36:57

AUSTIN, Texas, May 1, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, May 15, 2014, at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2014. Financial results will be issued in a press release prior to the call. Vermillion's Chairman, President and CEO James LaFrance will host the call, followed by a question and answer...

2014-04-28 08:31:08

-Specializes in Leading-Edge Biomarker Diagnostics for Gynecologic Cancers- AUSTIN, Texas, April 28, 2014 /PRNewswire/ -- Vermillion today launched ASPiRA LABS, which will specialize in applying the latest biomarker-based technologies to address critical needs in the management of gynecologic cancers. ASPiRA LABs will provide expert diagnostic processing and results using a state-of-the-art biomarker-based diagnostic algorithm to inform clinical decision making and advance...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related